当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息18(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Tyrosine-protein kinase BTK (ATK)
INDICATI
Approved B-cell lymphoma [ICD-11: 2A86]
INDICATI
Approved Diffuse large B-cell lymphoma [ICD-11: 2A81]
INDICATI
Approved Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Approved Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Approved Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Phase 3 Autoimmune disease [ICD-11: 4A40-4A45]
INDICATI
Phase 3 Spontaneous urticaria [ICD-11: EB00]
INDICATI
Phase 2 Lupus erythematosus [ICD-11: 4A40]
INDICATI
Phase 2 Pemphigus [ICD-11: EB40]
INDICATI
Preclinical Diabetes mellitus [ICD-11: 5A10]